More Investing
View Older Stories View Newer Stories-
Stellantis rating cut as analyst sees ’considerable downside risk to earnings’
-
Redburn lowers Adobe shares to Sell as GenAI erodes moat
-
IMF urges ECB to keep rates at 2% barring inflation shocks
-
UBS upgrades luxury sector but sees growth recovery delayed until H2 2026
-
Morgan Stanley highlights near-term opportunity in this China auto stock
-
U.S. private employers shed 33,000 jobs in June - ADP
-
Google, Microsoft electricity demand jumps over 25% for second year in a row
-
Tesla China sales rise slightly in June, ending 8-month decline
-
Renewables stocks rally as U.S. Senate drops excise tax
-
Netflix seeking to partner with Spotify on live TV projects, WSJ reports
-
Barclays begins coverage on six U.S. shopping center REITs, rates 2 stocks Buy
-
Lockheed Martin (LMT) secures $3 billion Aegis missile defense contract
-
US oil futures unchanged despite API showing surprise build in US crude stocks
-
Centene stock tumbles after withdrawal of 2025 guidance
-
JPMorgan Chase stock rises after $50 billion buyback, dividend hike
-
Design platform Figma files for U.S. IPO
-
Tariff rush lifts ASEAN exports, but BofA warns payback looms in H2
-
CD&R joins race for BP’s $8 billion Castrol unit, Sky News reports
-
Dollar nursing double-digit losses, but bears aren’t done yet: MS
-
Trump says not extending July 9th trade deadline, doubts deal with Japan
-
Nuclear microreactor stocks fall after DOE selects Westinghouse, Radiant for tests
-
Citi sees upside for Trade Desk into Q2 results, adds on a catalyst watch
-
UBS hires Morgan Stanley’s Taylor Henricks to head M&A in Americas
-
INmune slides again as Scotiabank, RJ cut ratings after Alzheimer’s drug miss
-
Wolfe Research refreshes high-conviction ideas heading into H2
-
Raymond James bumps Hyatt rating as $2 bln resort sale eases balance sheet worries
-
U.S. Senate passes ’big, beautiful bill’
-
BofA highlights Meta’s early AI gains and revenue momentum, reiterates Buy rating
-
Wall Street analysts start bullish on Omada Health on chronic care market growth
-
AstraZeneca stock rises amid reports CEO favors US listing move
-
ASML target cut at BofA on Foundry/Logic risks
-
Apple stock surges despite analysts' concerns over AI strategy shift
-
Nike recovery underway, analyst expects company to continue to dominate long-term
-
Tesla stock extends losses as Trump threatens to deport Musk
-
Medical device maker stocks falls after proposed Medicare payment cuts
-
Warner Bros. Discovery stock falls after Advance/Newhouse sells $1B stake
-
Needham charts path for Taiwan Semi to generate $90B in AI revenue by 2030
-
Goldman ups Oshkosh to Buy on ’inflecting Machinery supply, embedded tariff risks’
-
TD downgrades Sweetgreen as sales slump overshadows robot rollout
-
AI momentum could drive more gains for tech in second half: Wall Street
-
Total AV market could hit $1.2tn by 2040, says BofA
-
Tesla stock plunges as Trump threatens to deport Musk
-
BofA introduces the Top 10 U.S. Ideas for Q3 2025
-
Fed’s Müller says ECB can wait before further rate changes
-
Goldman rolls out latest U.S. Conviction List update
-
Macau casino stocks soar as June gaming revenue beats expectations
-
JPMorgan says Tesla demand weakness likely continued in second quarter
-
MSC Industrial stock gains despite Q3 earnings, revenue decline
-
BofA adds SAP stock to Top 10 EMEA ideas for Q3
-
DOGE’s overhaul of SEC targets SPAC and private fund rules
